The Performances of Spectral Domain Optical Coherence Tomography (OCT) for Distinguishing Glaucomatous Eyes (cirrusOCT)
This study has been completed.
Sponsor:
Prince of Songkla University
Information provided by:
Prince of Songkla University
ClinicalTrials.gov Identifier:
NCT01067482
First received: February 10, 2010
Last updated: March 22, 2010
Last verified: October 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
![](https://webarchive.library.unt.edu/web/20121019014347im_/http://www.clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
The purpose of this study is to evaluate performances of each parameters of spectral domain (Cirrus) optical coherence tomography for distinguishing between normal eyes, glaucoma suspect and glaucomatous eyes
Condition |
---|
Glaucoma Patient Glaucoma Suspect Patient Normal Population RNFL Thickness by Location Macular Thickness by Location |
Study Type: | Observational |
Study Design: | Time Perspective: Prospective |
Official Title: | The Performances of Spectral Domain Optical Coherence Tomography for Distinguishing Between Normal Eyes, Glaucoma Suspect and Glaucomatous Eyes |
Resource links provided by NLM:
Further study details as provided by Prince of Songkla University:
Estimated Enrollment: | 80 |
Study Start Date: | September 2009 |
Study Completion Date: | March 2010 |
Primary Completion Date: | March 2010 (Final data collection date for primary outcome measure) |
Groups/Cohorts |
---|
Glaucoma patients |
Glaucoma suspect group |
Normal population |
Detailed Description:
Aim to determine which parameter of cirrus OCT is best sensitivity and specificity for glaucoma detection
![](https://webarchive.library.unt.edu/web/20121019014347im_/http://www.clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Study Population
glaucoma patient from glaucoma clinic that is POAG Glaucoma suspect cases normal population case
Criteria
Inclusion Criteria:
- BCVA at least 20/60
- refractive error +/- 5 D Or astig +/- 3 D
- enrolled in 3 population group (glaucoma, glaucoma suspect or normal)
Exclusion Criteria:
- VA less than 20/60
- marked RF error
- previous ocular trauma or surgery
- unreliable visual field
- poor signal cirrus OCT (less than 7)
- other causes of optic nerve or macular disease other than glaucoma
![](https://webarchive.library.unt.edu/web/20121019014347im_/http://www.clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
Please refer to this study by its ClinicalTrials.gov identifier: NCT01067482
Locations
Thailand | |
Glaucoma unit , Department of Ophthalmology Faculty of Medicine Prince of Songkla University | |
Hat-yai,, Songkhla, Thailand., Thailand, 90110 |
Sponsors and Collaborators
Prince of Songkla University
Investigators
Principal Investigator: | Weerawat Kiddee, MD | Prince of Songkla University |
![](https://webarchive.library.unt.edu/web/20121019014347im_/http://www.clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
No publications provided
Responsible Party: | Weerawat Kiddee, Glaucoma unit , Department of Ophthalmology Faculty of Medicine Prince of Songkla University Hat-yai,, Songkhla, Thailand., Thailand |
ClinicalTrials.gov Identifier: | NCT01067482 History of Changes |
Other Study ID Numbers: | EC 52-336-02-1-2 |
Study First Received: | February 10, 2010 |
Last Updated: | March 22, 2010 |
Health Authority: | Thailand: Ethical Committee |
Keywords provided by Prince of Songkla University:
OCT spectral domain cirrus glaucoma glaucoma suspect normal population |
Additional relevant MeSH terms:
Glaucoma Ocular Hypertension Eye Diseases |
ClinicalTrials.gov processed this record on October 17, 2012